LUMOS PHARMA, INC. (LUMO) Retained Earnings (Accumulated Deficit) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Lumos Pharma, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2013 to 2024.
  • Lumos Pharma, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$172 M, a 27.5% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$172 M -$37.1 M -27.5% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$162 M -$34 M -26.7% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$152 M -$32.8 M -27.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$144 M -$31.8 M -28.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$135 M -$30.7 M -29.5% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 -$127 M -$31.1 M -32.2% Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$119 M -$28.5 M -31.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$112 M -$28.7 M -34.4% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 -$104 M -$29.5 M -39.6% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 -$96.4 M -$30.4 M -46.1% Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$90.8 M -$27.2 M -42.8% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 -$83.3 M -$18 M -27.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 -$74.6 M -$14.6 M -24.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$66 M -$6.31 M -10.6% Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$63.6 M +$262 M +80.5% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 -$65.3 M +$246 M +79% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 -$60 M +$241 M +80.1% Mar 31, 2020 10-Q 2020-06-02
Q4 2019 -$59.7 M +$231 M +79.5% Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$326 M -$45.3 M -16.1% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 -$311 M -$38.1 M -14% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$301 M -$45.3 M -17.7% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 -$291 M -$53.6 M -22.6% Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$280 M -$56.7 M -25.3% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 -$273 M -$69.9 M -34.4% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 -$256 M -$69.3 M -37.2% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 -$237 M -$72 M -43.5% Dec 31, 2017 10-K 2019-03-05
Q3 2017 -$224 M -$71.8 M -47.2% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 -$203 M -$66.7 M -48.9% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 -$186 M -$82.3 M -79.1% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 -$166 M -$85.2 M -106% Dec 31, 2016 10-K 2018-03-05
Q3 2016 -$152 M -$93.2 M -159% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 -$136 M -$100 M -279% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 -$104 M -$82.1 M -375% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 -$80.4 M -$40.4 M -101% Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$58.8 M +$101 M +63.3% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 -$36 M +$118 M +76.7% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 -$21.9 M Mar 31, 2015 10-Q/A 2015-08-24
Q4 2014 -$40 M +$96 M +70.6% Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$160 M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 -$154 M Jun 30, 2014 10-Q 2014-08-05
Q4 2013 -$136 M Dec 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.